Lrig1 anticorps (AA 1001-1093) (Cy3)
-
- Antigène Voir toutes Lrig1 Anticorps
- Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
-
Épitope
- AA 1001-1093
- Reactivité
- Humain, Souris, Rat
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Lrig1 est conjugé à/à la Cy3
-
Application
- Western Blotting (WB), Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))
- Réactivité croisée
- Humain, Souris, Rat
- Purification
- Purified by Protein A.
- Immunogène
- KLH conjugated synthetic peptide derived from human LRIG1
- Isotype
- IgG
- Top Product
- Discover our top product Lrig1 Anticorps primaire
-
-
- Indications d'application
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 - Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1 μg/μL
- Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
- Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- Stock
- -20 °C
- Stockage commentaire
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
- Date de péremption
- 12 months
-
- Antigène
- Lrig1 (Leucine-Rich Repeats and Immunoglobulin-Like Domains 1 (Lrig1))
- Autre désignation
- Lrig1 (Lrig1 Produits)
- Synonymes
- anticorps LIG-1, anticorps LIG1, anticorps D6Bwg0781e, anticorps Img, anticorps leucine rich repeats and immunoglobulin like domains 1, anticorps leucine-rich repeats and immunoglobulin-like domains 1, anticorps LRIG1, anticorps Lrig1
- Sujet
-
Synonyms: LIG1, LIG-1, Leucine-rich repeats and immunoglobulin-like domains protein 1, LRIG1
Background: Acts as a feedback negative regulator of signaling by receptor tyrosine kinases, through a mechanism that involves enhancement of receptor ubiquitination and accelerated intracellular degradation.
- ID gène
- 26018
- UniProt
- Q96JA1
-